Concepedia

Emma L. Akuffo

EL

2

Publications

110

Citations

2

H-Index

2008

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Emma L. Akuffo is an author at GlaxoSmithKline (United States) specializing in clinical trials, proteomics, and dementia.

Top concepts

HealthDementiaMedicineNeurologyBiomarkersProteomicsBiochemistryNeurosciencePharmacologyClinical Trials

Publications per year

2008–2008

2

Publications

2

Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium‐derived factor: Two novel biomarkers of Alzheimer's disease in human plasma

Paul Cutler, Emma L. Akuffo, Wanda M. Bodnar et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2008 · 56 citations

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

Emma L. Akuffo, John B. Davis, Steven M. Fox et al. · Biomarkers · 2008 · 54 citations

Neurochemical Biomarkers, Mild-to-moderate Alzheimer, Candidate Biomarkers +20

Rows per page

1–2 of 2